Overview
Propionibacterium freudenreichii is a Gram-positive, anaerobic to aerotolerant bacterium best known as the species responsible for the characteristic eyes (holes) and nutty flavor of Swiss-type cheeses. Beyond its industrial significance, P. freudenreichii has attracted growing research interest as a probiotic species with potential applications in colorectal cancer prevention, anti-inflammatory activity, and metabolic health through its production of short-chain fatty acids (SCFAs), particularly propionate and acetate.
The species represents a distinctive probiotic profile compared to the more commonly studied lactic acid bacteria, as its primary metabolic outputs are propionic acid and acetic acid rather than lactic acid, offering complementary benefits to the gut ecosystem.
Classification
P. freudenreichii belongs to the family Propionibacteriaceae within the phylum Actinomycetota (formerly Actinobacteria). It is a Gram-positive, non-motile, non-spore-forming, pleomorphic rod that can appear as short rods, coccoid forms, or branching filaments depending on growth conditions. The species is divided into two subspecies: subsp. freudenreichii and subsp. shermanii, both used in Swiss cheese production. The reference type strain is CIRM-BIA 129 (= DSM 20271). The species is characterized by its unique propionic acid fermentation pathway, converting lactate and glucose to propionate, acetate, and carbon dioxide.
Key Characteristics
The defining metabolic characteristic of P. freudenreichii is its propionic acid fermentation, which produces propionate, acetate, and carbon dioxide via the Wood-Werkman cycle. Propionate serves as an important energy substrate for colonic epithelial cells and may also function as a substrate for hepatic gluconeogenesis. Studies indicate that specific strains such as TL133 can survive gastrointestinal transit and significantly increase cecal concentrations of acetate, propionate, and butyrate, suggesting that P. freudenreichii may enhance overall SCFA availability in the colon.
The species has also demonstrated the ability to produce bifidogenic growth stimulators, compounds that selectively promote the growth of Bifidobacterium species, suggesting cross-feeding interactions that may support broader microbiome health.
Health Significance
The most compelling health application of P. freudenreichii relates to colorectal cancer prevention. Research indicates that the species may significantly reduce colonic aberrant crypt foci, a recognized biomarker of colorectal cancer risk, with one study demonstrating 56% inhibition in an animal model. The proposed mechanism involves SCFA-mediated induction of apoptosis in precancerous and cancerous colonocytes, with both propionate and acetate contributing to this anti-proliferative effect.
Additionally, P. freudenreichii has demonstrated anti-inflammatory and antioxidant properties in colonic tissue, with reductions in MDA oxidative stress markers and enhanced gut microbiota diversity reported in preclinical studies. The species' role in Swiss cheese production also means that regular consumption of Swiss-type cheeses may provide ongoing exposure to P. freudenreichii and its metabolites, though the viability and metabolic activity of the organism in the final cheese product varies with aging conditions. Further human clinical trials are needed to establish definitive health claims.